The pooled prevalence of long COVID was 12% among unvaccinated participants and 5% among recipients of at least two vaccine doses.
Review estimates 69% 3-dose vaccine efficacy against long COVID
More from COVID-19More posts in COVID-19 »
- Quick takes: School infection prevention, low US respiratory virus levels, polio in 3 nations
- Study: Kids with long COVID have impaired exercise capacity
- Global meta-analysis estimates 43% rate of multidrug resistance in COVID patients
- COVID-19 linked to increased preterm birth, other problems in pregnancy